Apollo Endosurgery, Inc.
DelistedCIK 1251769fmd_1S480YDQBK7S5AGVEY1CC58FH7Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2010 to Dec 31, 2022, 51 periods
| Line item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 8 | 5 | 68 | 65 | 64 | 61 | 51 | 42 | 63 | 77 |
| Cost of revenue | – | – | 21 | 25 | 25 | 28 | 25 | 20 | 28 | 34 |
| Gross profit | – | – | 47 | 39 | 40 | 33 | 26 | 22 | 35 | 42 |
| Research and development | 11 | 18 | 10 | 8 | 8 | 12 | 10 | 8 | 10 | 12 |
| Selling, general and administrative | – | – | 48 | 45 | 47 | 46 | 42 | 28 | 43 | 57 |
| Total operating expenses | 16 | 23 | 64 | 60 | 62 | 73 | 49 | 38 | 54 | 74 |
| Operating income | (8) | (18) | (17) | (21) | (22) | (40) | (24) | (16) | (19) | (31) |
| Interest expense | – | – | 10 | 18 | 5 | 4 | 4 | 5 | 8 | 5 |
| Other non-operating income (expense) | 1 | 1 | 0 | – | – | (1) | 0 | (1) | 0 | (3) |
| Income before taxes | – | – | (27) | (41) | (27) | (46) | (27) | (22) | (25) | (39) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Net income from continuing operations | – | – | (27) | (41) | (27) | (46) | (27) | (23) | (25) | (40) |
| Net income | – | – | (27) | (41) | (27) | (46) | (27) | (23) | (25) | (40) |
| Net income to common shareholders | (7) | (17) | (36) | (41) | – | – | – | – | – | – |